Comparison of Buprenorphine and Magnesium Sulfate as Adjuncts to Intrathecal Hyperbaric Bupivacaine for Lower Abdominal Surgeries
Authors/Creators
- 1. Senior Resident, Department of Anaesthesiology, ANNMCH, Gaya
- 2. Associate Professor & Head, Department of Anaesthesiology, ANNMCH, Gaya
Description
Background: An adjuvant to a local anaesthetic can potentiate spinal anesthesia and provide better postoperative analgesia. Our study has been drafted to evaluate and compare the analgesic potency of the adjuvants, buprenorphine and magnesium, to intrathecal 0.5% hyperbaric bupivacaine. Methods: One hundred and fifty patients by inclusion criteria posted for an elective lower abdominal surgery were randomized into three groups of 50 each. They received 3ml of 0.5% hyperbaric bupivacaine with either 1ml of 0.9% Saline or 1ml of buprenorphine (60μg) or 1ml of magnesium sulphate (50mg). Time for first rescue analgesia, onset of sensory and motor blocks, time to two-segment regression and duration of motor block, haemodynamic parameters, and side effects were studied. Data was analyzed with ANOVA, Kruskal-Wallis H, Chi-square and Fischer’s exact tests. Our Study was carried out from April 2020 to March 2021. Results: The time for first analgesic request was 248.70> 186.84> 141.44 minutes, (Buprenorphine> magnesium> control), p<0.001. The onset of sensory and motor blocks was faster in buprenorphine group compared to magnesium and control groups. The time to two-segment regression and duration of motor block was significantly prolonged in buprenorphine and magnesium groups compared to control group. Conclusion: The time to first analgesic request was longer with buprenorphine compared to magnesium sulphate with adequate sedation and negligible complications. Hence, addition of adjuvant buprenorphine (60μg) has a better demonstrable role in postoperative analgesia compared to adjuvant magnesium (50mg) or 0.5% hyperbaric bupivacaine alone.
Abstract (English)
Background: An adjuvant to a local anaesthetic can potentiate spinal anesthesia and provide better postoperative analgesia. Our study has been drafted to evaluate and compare the analgesic potency of the adjuvants, buprenorphine and magnesium, to intrathecal 0.5% hyperbaric bupivacaine. Methods: One hundred and fifty patients by inclusion criteria posted for an elective lower abdominal surgery were randomized into three groups of 50 each. They received 3ml of 0.5% hyperbaric bupivacaine with either 1ml of 0.9% Saline or 1ml of buprenorphine (60μg) or 1ml of magnesium sulphate (50mg). Time for first rescue analgesia, onset of sensory and motor blocks, time to two-segment regression and duration of motor block, haemodynamic parameters, and side effects were studied. Data was analyzed with ANOVA, Kruskal-Wallis H, Chi-square and Fischer’s exact tests. Our Study was carried out from April 2020 to March 2021. Results: The time for first analgesic request was 248.70> 186.84> 141.44 minutes, (Buprenorphine> magnesium> control), p<0.001. The onset of sensory and motor blocks was faster in buprenorphine group compared to magnesium and control groups. The time to two-segment regression and duration of motor block was significantly prolonged in buprenorphine and magnesium groups compared to control group. Conclusion: The time to first analgesic request was longer with buprenorphine compared to magnesium sulphate with adequate sedation and negligible complications. Hence, addition of adjuvant buprenorphine (60μg) has a better demonstrable role in postoperative analgesia compared to adjuvant magnesium (50mg) or 0.5% hyperbaric bupivacaine alone.
Files
IJPCR,Vol16,Issue5,Article261.pdf
Files
(377.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c308ad2814fa21a5de2d8fc8a7b15809
|
377.2 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-04-28
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue5,Article261.pdf
- Development Status
- Active
References
- 1. Bogra J, Arora N, Srivastava P. Synergistic effect of intrathecal fentanyl and bupivacaine in spinal anesthesia for cesarean section. BMC Anesthesiology 2005;5. 2. Capogna G, Celleno D, Tagariello V, LoffredaMancinelli C. Intrathecal buprenorphine for postoperative analgesia in the elderly patient. Anaesthesia 2007; 43: 12 8-130.3. Mayer M, Westbrook G, Guthrie P. Voltagedependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984;309 :2 61- 263. 4. Theerth K, Kurdi M. Comparison of Intrathecal Magnesium Sulphate and Intrathecal Buprenorphine Used as Adjuvants to Hyperbaric Bupivacaine: A Prospective Randomized Double Blind PlaceboControlled Study. J Anesth Res Pain Med 2016; 1:8-21. 5. Ramsay M. Acute Postoperative Pain Management. Proc (Bayl Univ Med Cent) 2000; 13:244-247. 6. Ding Z, Raffa R. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol 2009; 157:831-843. 7. Woolf C, Thompson S. The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of postinjury pain hypersensitivity states. Pain 1991; 44:293-299. 8. Wang J, Nauss L, Thomas J. Pain Relief by Intrathecally Applied Morphine in Man. Anesthesiology 1979;50:149-151. 9. Ravindran R, Sajid B, Ramadas K, Susheela I. Intrathecal hyperbaric bupivacaine with varying doses of buprenorphine for postoperative analgesia after cesarean section: A comparative study. Anesth Essays Res 2017;11: 952. 10. Dalai H, Nanda S, Chavali S. A Clinical Comparison between Intrathecal and Intravenous Infusion of Magnesium Sulphate as an Adjuvant to Hyperbaric 0.5% Bupivacaine in Spinal Anaesthesia for Elective Infraumbilical Surgeries. Annals of International medical and Dental Research 2017;3. 11. Dutta D, Khandelwal M, Bafna U, Chauhan S, Jetley P, Mitra S. Comparison of intrathecal clonidine and magnesium sulphate used as an adjuvant with hyperbaric bupivacaine in lower abdominal surgery. Indian J Anaesth 2017; 61:667. 12. Khezri MB, Yaghobi S, Hajikhani M, Asefzadeh S. Comparison of postoperative analgesic effect of intrathecal magnesium and fentanyl added to bupivacaine in patients undergoing lower limb orthopedic surgery. Acta Anaesthesiol Taiwan. 2012; 50:19-24. 13. Khalili G, Janghorbani M, Sajedi P, Ahmadi G. Effects of adjunct intrathecal magnesium sulfate to bupivacaine for spinal anesthesia: a randomized, double-blind trial in patients undergoing lower extremity surgery. J Anesth 2011;25: 892-897. 14. Hemalatha P, Banu N, Rao M, Samantaray A, Venkatraman A, Hemanth N. Comparison of two different doses of magnesium sulphate for spinal anaesthesia: a prospective, randomized double-blind study. JCSR. 2017; 6:18. 15. Hung Y-C, Chen C-Y, Lirk P, Wang C-F, Cheng J-K, Chen C-C, et al. magnesium sulfate diminishes the effects of amide local anesthetics in rat sciatic-nerve block. Reg Anesth Pain Med 2007; 32:288–95. 16. Okutomi T, Saito M, Matsumoto Y, Shimizu M, Fukuoka M, Hoka S. Altered bupivacaine pharmacokinetics by MgSO4 in rats. Can J Anaesth 2004; 51:93-94. 17. Iyer S, Kaur N, Goneppanavar U, Venkateswaran R. Comparative effects of buprenorphine and dexmedetomidine as adjuvants to bupivacaine spinal anaesthesia in elderly male patients undergoing transurethral resection of prostrate: A randomized prospective study. Anesth Essays Res. 2017; 11:886. 18. Shukla D, Verma A, Agarwal A, Pandey HD, Tyagi C. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine. J Anaesthesiol Clin Pharmacol 2011; 27:495–9. 19. Patil S, Debata D, Doshi C, Vyas V, Sinha S. Effect of buprenorphine as an adjunct with plain local anesthetic solution in supraclavicular brachial plexus block on quality and duration of postoperative analgesia. J Anaesthesiol Clin Pharmacol 2015; 31:496–500. 20. Vadhanan P, Tripaty DK, Adinarayanan S. Physiological and pharmacologic aspects of peripheral nerve blocks. J Anaesthesiol Clin Pharmacol 2015; 31:384–93.